Advicenne announces its financial calendar for 2022
December 27, 2021
Paris, France, December 27, 2021, 7 :00AM (CET) – Advicenne (Euronext: ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, releases its financial Calendar for 2022.